ELIXIRON IMMUNOTHERAPEUTICS, INC

Organization

TAIPEI CITY, TW

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-PD-L1 antibodies and anti-PD-L1/IL10 fusion proteins
- Patent number 11,773,167
- Issue date Oct 3, 2023
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-colony stimulating factor 1 receptor (CSF1R) antibodies and me...
- Patent number 11,396,549
- Issue date Jul 26, 2022
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-interferon gamma antibodies and uses thereof
- Patent number 10,968,274
- Issue date Apr 6, 2021
- Elixiron Immunotherapeutics (Hong Kong) Limited
- Cheng-Lun Ku
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treatment of HBV infection
- Patent number 10,813,974
- Issue date Oct 27, 2020
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF TREATING DISEASES WITH ANTI-PD-L1/IL-10 FUSION PROTEINS
- Publication number 20240336667
- Publication date Oct 10, 2024
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED INTERLEUKIN-10 AND FUSION PROTEINS THEREOF
- Publication number 20240190934
- Publication date Jun 13, 2024
- Elixiron Immunotherapeutics (Hong Kong) Limited
- Hung-Kai Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1 ANTIBODIES AND ANTI-PD-L1/IL10 FUSION PROTEINS
- Publication number 20240182578
- Publication date Jun 6, 2024
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1 ANTIBODIES AND ANTI-PD-L1/IL10 FUSION PROTEINS
- Publication number 20230078173
- Publication date Mar 16, 2023
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CSF1R ANTIBODIES, IL10 FUSION PROTEINS, AND USES THEREOF
- Publication number 20210403583
- Publication date Dec 30, 2021
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR AND...
- Publication number 20210309732
- Publication date Oct 7, 2021
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Cheng-Lun KU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF
- Publication number 20210171624
- Publication date Jun 10, 2021
- Elixiron Immunotherapeutics (Hong Kong) Limited
- Cheng-Lun KU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF
- Publication number 20210171625
- Publication date Jun 10, 2021
- Elixiron Immunotherapeutics (Hong Kong) Limited
- Cheng-Lun KU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF
- Publication number 20210054066
- Publication date Feb 25, 2021
- Elixiron Immunotherapeutics (Hong Kong) Limited
- Cheng-Lun KU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATMENT OF HBV INFECTION
- Publication number 20200289603
- Publication date Sep 17, 2020
- ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
- Hung-Kai CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
97681739 - T-ACTION
- Serial number 97681739
- Filing date Nov 17, 2022
- Elixiron Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations

ELIXIRON IMMUNOTHERAPEUTICS, INC

Organization

Patents Grantslast 30 patents

Anti-PD-L1 antibodies and anti-PD-L1/IL10 fusion proteins

Anti-colony stimulating factor 1 receptor (CSF1R) antibodies and me...

Anti-interferon gamma antibodies and uses thereof

Methods for treatment of HBV infection

Patents Applicationslast 30 patents

METHOD OF TREATING DISEASES WITH ANTI-PD-L1/IL-10 FUSION PROTEINS

ENGINEERED INTERLEUKIN-10 AND FUSION PROTEINS THEREOF

ANTI-PD-L1 ANTIBODIES AND ANTI-PD-L1/IL10 FUSION PROTEINS

ANTI-PD-L1 ANTIBODIES AND ANTI-PD-L1/IL10 FUSION PROTEINS

ANTI-CSF1R ANTIBODIES, IL10 FUSION PROTEINS, AND USES THEREOF

ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR AND...

ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF

ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF

ANTI-INTERFERON GAMMA ANTIBODIES AND USES THEREOF

METHODS FOR TREATMENT OF HBV INFECTION

Trademarklast 30 trademarks

97681739 - T-ACTION